PHSA 17603 - PHSA 17603 Testiscan & Wavelength II (Канада - Тендер #68655124) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Канада (другие тендеры и закупки Канада) Организатор тендера: www.merx.com Номер конкурса: 68655124 Дата публикации: 19-11-2025 Источник тендера: www.merx.com |
||
A direct contract award for a custom-made NIRS optical probe (Testiscan) with WaveMaster II system designed for assessment of scrotal content in children and adults.
00004799859
Issuing OrganizationProvincial Health Services Authority BC
Solicitation TypeNOI - Notice of Intent (Informal)
Solicitation NumberPHSA 17603
TitlePHSA 17603 Testiscan & Wavelength II
Source IDSCRIBE
British Columbia
Purchase TypeNot Stated
2025/11/19 08:04:00 AM EST
Closing Date2025/11/28 03:00:00 PM EST
Manish Chauhan
manish.chauhan@phsa.ca
Notice is hereby given that Vancouver Coastal Health Authority (the “Health Authority”), through it’s agent Provincial Health Services Authority (“PHSA”), intends to directly award a
Contract to the following supplier to provide one (1) Testiscan & Wavelength II for Vancouver Prostate Centre at an estimated value of $114,000 plus applicable taxes.
NRSign 3570,48thWestAve, Vancouver BC V6N 3R1
In accordance with applicable trade agreements PHSA, as agent for the Vancouver Coastal Health Authority has chosen not to proceed with a competitive process for the following reason:
•the goods or services can be supplied only by the selected supplier and no alternative or substitute exists for the following reason:
(a) due to an absence of competition for technical reasons
The required NIRS optical probe (Testiscan) with WaveMaster II system is a custom-made, multi-channel device with exchangeable emitters for variable depth of penetration, designed by Dr.
Kourosh Afshar for assessment of scrotal content in children and adults. This state-of-the-art research equipment is not commercially available, and only this vendor can meet all required
specifications. The unit will be used solely for UBC-approved clinical research, and no other vendor can provide an equivalent product.
Vendors who wish to challenge this decision should submit a detailed written objection for the attention of Manish Chauhan, by email before 12:00pm Pacific Time, November 28 2025. PHSA will
review any and all issues received by this date and provide due consideration to each objection.
Please Reference File: # PHSA 17603 on all written correspondence.